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Abstract: 
Background: Rhupus is a rare clinical condition where rheumatoid arthritis (RA) and 
systemic lupus erythematosus (SLE) overlap and is characterized by the presence of 
erosive arthritis with symptoms and signs of SLE. This study aims to investigate the 
prevalence of anti-CCP antibodies in SLE patients from CHU BLIDA (Immunology 
unit) and its association with anti-DNA and Anti Sm, in order to make a diagnosis of 
rhupus among our patients.  
Methods: Our retrospective study included 96 patients fulfilling the American College 
of Rheumatology (ACR) classification criteria for lupus. anti-CCP antibodies, anti-Sm 
were analyzed by  ELISA, anti-DNA antibodies were determined by both IFI on 
Crithidia luciliae substrate and  ELISA. The FR by Laser Nephelemetry. Inclusion 
criteria are the presence of at least one immunological marker of LES with anti-CCP. 
The sex ratio F / H is equal to 13/1, where the average age is 37 years. 
Results: Anti-CCP was found in 14 patients  (14.6% ), 56.25% and 39.59%  had 
positive anti-DNA and antiSm respectively; rheumatoid factors (RF) were positive in 
27.08% of cases; anti-CCP / FR combination was found in 7.3% of cases. Besides, the 
combination of anti-CCP and anti-DNA was found in 12.5%. These two 
autoantibodies were simultaneously absent in 49.92% of cases. Arthritis was found in 
80 patients. Our results concerning the prevalence of immunological and clinical 
markers of RA such as anti-CCP, RF and arthritis in our lupus patients corroborate 
with those of the literature. 
Conclusion: Based on the presence of shared clinical features of RA and SLE along 
with the presence of anti-DNA and anti-CCP antibodies in our patients, our findings 
strongly support the contention that rhupus is a true overlap between RA and SLE. 
Despite being a rare entity, it is important to know the clinical and humoral elements 
that allow its early diagnosis, making it easier to start treatment in a timely manner and 
reduce its possible complications. 
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